This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
DeVita, V.T. 1983. Progress in cancer management. Cancer 51:2401–2409.
Oldham, R.K. 1987. Biotherapy: general principles, pp. 1–20 in Principles of Cancer Biotherapy. R. K. Oldham (ed.). Raven Press, New York.
Fidler, I.J. and Poste, G. 1985. The cellular heterogeneity of malignant neoplasms: Implications for adjuvant chemotherapy. Semin. Oncol. 12:207–221.
Busch, W. 1868. Niederrheinische Gesellschaft fur Natur-und Heilkunde in Bonn. Aus der Sitzung der Medizinischen Sektion vom 13. November 1867. Berlin. Klin. Wschr. 5:137–139.
Coley, W.B. 1891. Contribution to the knowledge of sarcoma. Ann. Surg. 14:199–220.
Fidler, I.J. 1984. The generation of tumoricidal activity in macrophages for the treatment of established metastases, pp. 421–437 in Cancer Invasion and Metastases: Biological and Therapeutic Aspects. G. L. Nicholson and L. Milas (eds.), Raven Press, New York.
Goodright, J.E. and Morton, D.C. 1978. Immunotherapy for malignant disease. Ann. Rev. med. 29:231–253.
Oldham, R.K. and Smalley, R.V. 1984. Immunotherapy: the old and the new. J. Biol. Resp. Modif. 2:1–37.
Diagnostic and therapeutic technology assessment. BCG immunotherapy in bladder cancer: a reassessment. 1988. JAMA 259:2143–2155.
Kawagoe, K. and Masuda, H. 1986. Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK432. Jpn. J. Clin. Oncol. 16:137–142.
Goldstein, D., Laszlo, J. and Rudnick, S. 1987. Interferon in cancer therapy, pp. 247–272 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
Hercerd, T. and Schmidt, R.E. 1988. Characteristics and uses of natural killer cells. Immunology Today 9:291–293.
Rosenberg, S.A., Lotze, M.T., Muul, L.M., Leitman, S., Chang, A.E., Ettinghausen, S.E., Matory, Y.L., Skibber, J.M., Shiloni, E., Vetto, J.T., Seipp, C.A., Simpson, C. and Reichert, C.M. 1985. Observations on the systemic administration of autologous lymphokine activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl. J. Med. 313:1485–1492.
Rosenberg, S.A., Speiss, P. and La Frenieve, R. 1986. A new approach to the adoptive immunotherapy of cancer with tumor infiltrating lymphocytes. Science 233:1318–1321.
Stevenson, H.C. and Stevenson, G.W. 1987. Adoptive cellular cancer immunotherapy, pp. 385–397 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
Sivam, G., Pearson, J.W., Bohn, W., Oldham, R.K., Sadoff, J.C. and Morgan, A.C. 1987. Immunotoxins to a human melanoma associated antigen: comparison of gelonin with Ricin and other A-chain conjugates. Cancer Res. 47:3169–3173.
Reading, C.L. and Takane, Y. 1986. Monoclonal antibody applications in bone marrow transplantation. Biochem. Biophys. Acta. 865:141–170.
Moore, M.A.S. 1987. Growth and maturation factors in leukemia, pp. 399–446 in Principles of Cancer Biotherapy. R. K. Oldham (ed.), Raven Press, New York.
Masui, H., Kawamoto, T., Sato, J.D., Wolf, B., Sato, G. and Mendelsohn, J. 1984. Growth inhibition of human tumor cells in athymic nude mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res. 44:1002–1007.
Hanna, M.G. and Key, M.E. 1982. Immunotherapy of metastases enhances subsequent chemotherapy. Science 217:367–369.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCall, C., Weimer, L., Baldwin, S. et al. Biotherapy: A New Dimension in Cancer Treatment. Nat Biotechnol 7, 231–240 (1989). https://doi.org/10.1038/nbt0389-231
Issue Date:
DOI: https://doi.org/10.1038/nbt0389-231